Company: SABR
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049383
Chunk: 330

Company: Sabre Corp
Filing Date: 2025-11-05
Form: 10-Q
Item: Part II, Item 7
Chunk 330
---
 pursuant to the Share Repurchase Program. As of September 30, 2025, the Share Repurchase Program remains suspended and approximately $287 million remains authorized for repurchases. In addition, the terms of certain of the agreements governing our indebtedness contain covenants that, among other things, limit our ability to repurchase our common stock. See “Risk Factors—The terms of our debt covenants could limit our discretion in operating our business and any failure to comply with such covenants could result in the default of all of our debt.” 

35

Cash Flows

 Nine Months Ended September 30, 20252024(Amounts in thousands)Cash used in operating activities$(248,155)$(5,463)Cash used in investing activities(50,352)(10,307)Cash (used in) provided by financing activities(804,408)46,049 Cash provided by (used in) discontinued operations1,035,759 (9,898)Effect of exchange rate changes on cash, cash equivalents and restricted cash4,385 176 (Decrease) increase in cash, cash equivalents and restricted cash$(62,771)$20,557 

Operating Activities

Cash used in operating activities totaled $248 million for the nine months ended September 30, 2025. The $243 million decrease in operating cash flow from the same period in the prior year was primarily due to payments in June 2025 of previously paid-in-kind interest and currently accrued interest of $227 million in connection with refinancing our Senior Secured Term Loan Due 2028 and a contribution of $14 million to our defined benefit pension plan, offset by a $19 million decrease in interest payments in connection with our other debt.

Investing Activities

For the nine months ended September 30, 2025, we used $59 million of cash for capital expenditures primarily related to software developed for internal use, partially offset by the proceeds received from the sale of assets of $9 million.

For the nine months ended September 30, 2024, we used $65 million of cash for capital expenditures primarily related to software developed for internal use and acquired software licenses associated with our internal billing systems, partially offset by proceeds received from the sale of investment in securities of $55 million.

Financing Activities

For the nine months ended September 30, 2025, financing activities used $804 million. Significant highlights of our financing activities include:

•payments of $806 million